Dear Colleague:

The Section of Dermatology at the University of Chicago is conducting a research survey of board-certified dermatologists about drug-compounding legislation and its effects on patients and providers.

According to the federal government, compounding is a practice in which the ingredients of a drug are combined, mixed, or altered to create a medication tailored to the needs of an individual patient.

The following are a few examples of drugs commonly used by dermatologists that would fall under this definition:

  • Lidocaine buffered with bicarbonate,
  • Intralesional triamcinolone (Kenalog) diluted to a custom dilution,
  • Reconstituted botulinum toxin,
  • Certain topical anesthetic creams (i.e. 23/7 cream: lidocaine 23%, tetracaine 7%)

In-office compounded medications such as those above, may become limited to certain pharmacies rather than practicing physicians under possible legislative changes at the state and federal levels.

While dermatologists are likely to be one of the medical specialties most affected by new legislation, there have been no national surveys of the practice patterns of dermatologists with regard to compounding.

We would appreciate your participation in our survey in order to better inform ongoing policy discussions on this topic.

All of the data will be coded and stored in a secure Internet server. We expect the survey to take less than 10 minutes to complete. We do not anticipate any negative impact on you from taking our survey, and there will be no consequences if you choose not to participate.

This research is supported by a grant through the American Society of Dermatologic Surgery.

If you have questions about the survey, please contact K. Yazmin Reyna-Blanco, the project coordinator at kreynablanco@medicine.bsd.uchicago.edu or 773-702-7696.

Thank you for your support!

Loading... Loading...
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.